Triple

T21327540
Position Surface form Disambiguated ID Type / Status
Subject Larry Bock E525800 entity
Predicate coFounded P104 FINISHED
Object Idun Pharmaceuticals
Idun Pharmaceuticals is a biotechnology company focused on developing therapies that regulate cell death pathways, particularly apoptosis, for the treatment of various diseases.
 E1478650 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Idun Pharmaceuticals | Statement: [Larry Bock, coFounded, Idun Pharmaceuticals]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Idun Pharmaceuticals
Context triple: [Larry Bock, coFounded, Idun Pharmaceuticals]
  • A. Idera, Inc.
    Idera, Inc. is a software company best known for its database management, performance monitoring, and developer tools used by IT professionals and enterprises.
  • B. Portola Pharmaceuticals
    Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
  • C. Elan Pharmaceuticals
    Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
  • D. Millennium Pharmaceuticals
    Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
  • E. Innogen
    Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Idun Pharmaceuticals
Triple: [Larry Bock, coFounded, Idun Pharmaceuticals]
Generated description
Idun Pharmaceuticals is a biotechnology company focused on developing therapies that regulate cell death pathways, particularly apoptosis, for the treatment of various diseases.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Idun Pharmaceuticals
Target entity description: Idun Pharmaceuticals is a biotechnology company focused on developing therapies that regulate cell death pathways, particularly apoptosis, for the treatment of various diseases.
  • A. Idera, Inc.
    Idera, Inc. is a software company best known for its database management, performance monitoring, and developer tools used by IT professionals and enterprises.
  • B. Portola Pharmaceuticals
    Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
  • C. Elan Pharmaceuticals
    Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
  • D. Millennium Pharmaceuticals
    Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
  • E. Innogen
    Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b51b90788190a4dd823d962626da completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e7ab4d69b4819088649e34213d0b67 completed April 21, 2026, 4:52 p.m.
NED1 Entity disambiguation (via context triple) batch_6a09a5ba86c08190b1193cb403e2edda completed May 17, 2026, 11:25 a.m.
NEDg Description generation batch_6a09a653f0108190ac0881f63865222e completed May 17, 2026, 11:28 a.m.
NED2 Entity disambiguation (via description) batch_6a09a6e82b3881908bb85f0d7fe3d6d9 completed May 17, 2026, 11:30 a.m.
Created at: April 16, 2026, 4:41 p.m.